Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Description

Farmavita.Net member is offering Metformin, tablets 500-850 mg, bulk supply with license for use  of EU CTD Dossier. Registration is going-on in Bulgaria.

Offer is valid subject to confirmation, country by country.

INDICATIONS AND USE

Metformin hydrochloride, tablets,  as monotherapy, are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. Metformin is indicated in patients 10 years of age and older. Metformin may be used concomitantly with a sulfonylurea or insulin to improve glycemic control in adults (17 years of age and older).

Mechanism of Action

Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.

More details at http://www.rxlist.com/cgi/generic/metformi.htm 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 51

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
395 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
330 Views
Profitable and Modern Russian CMO with long...
314 Views
Adalimumab API available: - from EU cGMP...
10013 Views
Infliximab API available: - from EU cGMP...
334 Views
Normal 0 false false false EN-US X-NONE HE /*...
326 Views
Start-up pharmaceutical company from South...
1662 Views